arrow
C

Charles B. Stevenson

cincinnati children's hospital medical center
H指数:23
被引数:2,126

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A CAR-T tonic signaling code predicts anti-tumor efficacy in diffuse midline glioma

CAR-T细胞稳态信号编码可预测弥漫性中线胶质瘤的抗肿瘤疗效

2026-08-310
PRE
Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis

撤回注意: 人类胎儿小脑细胞图谱提示髓母细胞瘤的起源和肿瘤发生

Nature
IF48.5
2025-07-090
PRE
A PHASE I STUDY OF INTRATUMORAL/PERITUMORAL HERPES SIMPLEX VIRUS-1 MUTANT HSV1716 IN PATIENTS WITH REFRACTORY OF RECURRENT HIGH-GRADE GLIOMAS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

复发性高级别神经胶质瘤难治性患者的瘤内/瘤周单纯疱疹病毒-1突变体HSV1716的I期研究: 小儿脑肿瘤联盟研究

2024-06-180
OAAI
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report

瑞博西尼和依维莫司在新诊断的DIPG和高级别神经胶质瘤患儿中的I期研究: 小儿神经肿瘤学联合会的报告

2022-04-168
OAAI
Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas

表征小儿低度神经胶质瘤的时间基因组异质性

2020-11-0511
OAAI
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)

新诊断的弥漫性内源性桥脑胶质瘤 (DIPG) 患儿放射治疗后瑞博西尼的I/II期研究

2020-10-0929
PREAI
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas

表征小儿高级别神经胶质瘤的时间基因组异质性

2017-10-3047
OAAI
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study

imetelstat (GRN163L) 在复发性或难治性中枢神经系统恶性肿瘤患儿中的分子生物学和II期研究: 小儿脑肿瘤联盟研究

2016-06-2778
OAAI
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics (vol 4, 1, 2016)
2016-02-095
OAAI
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
2016-01-04113
OA